中华麻醉学杂志2024,Vol.44Issue(12) :1456-1459.DOI:10.3760/cma.j.cn131073.20240715.01211

年龄因素对复合丙泊酚时奥赛利定抑制胃镜置入反应效力的影响

Effect of age factor on potency of oliceridine in inhibiting responses to gastroscopic implantation when combined with propofol

贾佳 李帼双 张贝贝 张加强 张伟
中华麻醉学杂志2024,Vol.44Issue(12) :1456-1459.DOI:10.3760/cma.j.cn131073.20240715.01211

年龄因素对复合丙泊酚时奥赛利定抑制胃镜置入反应效力的影响

Effect of age factor on potency of oliceridine in inhibiting responses to gastroscopic implantation when combined with propofol

贾佳 1李帼双 2张贝贝 1张加强 1张伟1
扫码查看

作者信息

  • 1. 河南省人民医院(郑州大学人民医院)麻醉与围术期医学科,郑州 450003
  • 2. 新乡医学院研究生院,新乡 453003
  • 折叠

摘要

目的 评价年龄因素对复合丙泊酚时奥赛利定抑制胃镜置入反应效力的影响.方法 本研究为前瞻性试验.选择拟行无痛胃镜检查术患者,性别不限,ASA分级Ⅰ或Ⅱ级,BMI 18~27 kg/m2.根据年龄分为2组:成年组(A组:年龄18~65岁)和老年组(E组:年龄>65岁).静脉注射奥赛利定2 min后缓慢静脉注射丙泊酚1.5 mg/kg,待患者睫毛反射消失、下颌松弛后开始胃镜检查.采用改良Dixon序贯法进行试验,奥赛利定起始剂量为0.015 mg/kg,相邻药物剂量比值为1.0:1.2,若进镜时患者出现吞咽、呛咳、体动反应等影响检查操作的反应为阳性,下一例患者增加1个剂量梯度,否则视为阴性,下一例患者降低1个剂量梯度,重复此过程直至出现7个转折.采用probit回归法计算复合丙泊酚时奥赛利定抑制胃镜置入反应的半数有效剂量(ED50)及其95%置信区间(95%CI).结果 A组和E组患者复合丙泊酚时奥赛利定抑制胃镜置入反应的ED50(95%CI)分别为0.015(0.007~0.023)mg/kg 和 0.012(0.007~0.017)mg/kg.2 组 ED50比较差异无统计学意义(P>0.05).结论 年龄因素对复合丙泊酚时奥赛利定抑制胃镜置入反应的效力无明显影响.

Abstract

Objective To evaluate the effect of age factor on the potency of oliceridine in inhibiting responses to the gastroscopic implantation when combined with propofol.Methods This was a prospective study.American Society of Anesthesiologists Physical Status classification Ⅰ or Ⅱ patients of either sex,with a body mass index of 18-27 kg/m2,undergoing elective painless gastroscopy,were divided into 2 groups based on age:adult group(group A:age 18-65 yr)and elderly group(group E:age>65 yr).Propofol 1.5 mg/kg was slowly injected intravenously 2 min after intravenous injection of oliceridine.Gastroscopy was performed after the patient's eyelash reflex disappeared and the jaw was relaxed.The optimal dose was deter-mined by modified Dixon's up and down method.The initial dose of oliceridine was 0.015 mg/kg,and the ratio between the two successive concentrations was 1.0:1.2.If the patient had a positive response that af-fected the examination operation such as swallowing,bucking and body movement during insertion of the gastroscope,the next patient received a higher dose,or conversely if negative,and a lower dose was given in the next patient.This process was repeated until the 7th turning point occurred.The median effective dose(ED50)and 95%confidence interval of oliceridine in inhibiting responses to gastroscopic implantation were calculated by probit method.Results The ED50(95%confidence interval)of oliceridine in inhibiting re-sponses to gastroscopic implantation was 0.015(0.007-0.023)mg/kg and 0.012(0.007-0.017)mg/kg in group A and group E,respectively.There was no significant difference in ED50 between the two groups(P>0.05).Conclusions Age factor has no significant effect on the potency of oliceridine in inhibiting respon-ses to gastroscopic implantation when combined with propofol.

关键词

年龄因素/镇痛药,阿片类/二异丙酚/胃镜检查/剂量效应关系,药物

Key words

Age factors/Analgesics,opioid/Propofol/Gastroscopy/Dose-response rela-tionship,drug

引用本文复制引用

出版年

2024
中华麻醉学杂志
中华医学会

中华麻醉学杂志

CSTPCDCSCD北大核心
影响因子:1.235
ISSN:0254-1416
段落导航相关论文